Literature DB >> 15809288

Maturation requirements for dendritic cells in T cell stimulation leading to tolerance versus immunity.

Jonathan K H Tan1, Helen C O'Neill.   

Abstract

The model that dendritic cell (DC) "maturation" describes the change from an immature, antigen-capturing cell to a mature, antigen-presenting cell is well-established. Classification of DCs in terms of function has been problematic previously. It is therefore proposed that mature and not immature DCs are responsible for antigen presentation and stimulation of T cells. Furthermore, DC antigen presentation to T cells can have two outcomes: tolerance or immunity. The particular outcomes appear to be determined by the activation state of the mature DC. DCs can be activated by a range of environmental stimuli or "danger signals". Here, the hypothesis is advanced that activated, mature DCs induce T cell immunity, and resting, nonactivated but fully differentiated mature antigen-presenting DCs can induce tolerance. This proposal extends to conventional DCs and plasmacytoid DCs. The paper also concentrates on the spleen as a site for DC maturation, in light of evidence from this laboratory for differentiation of DCs from splenic precursors in long-term, stroma-dependent cultures. The hypothesis advanced here serves to simplify many current issues regarding DC maturation and function.

Mesh:

Year:  2005        PMID: 15809288     DOI: 10.1189/jlb.1104664

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  43 in total

Review 1.  T-cell based immunotherapy in experimental autoimmune encephalomyelitis and multiple sclerosis.

Authors:  Kate O'Brien; Bruno Gran; Abdolmohamad Rostami
Journal:  Immunotherapy       Date:  2010-01       Impact factor: 4.196

Review 2.  The Importance of Dendritic Cells in Maintaining Immune Tolerance.

Authors:  Cindy Audiger; M Jubayer Rahman; Tae Jin Yun; Kristin V Tarbell; Sylvie Lesage
Journal:  J Immunol       Date:  2017-03-15       Impact factor: 5.422

3.  Modifying Dendritic Cell Activation with Plasmonic Nano Vectors.

Authors:  Kieng Bao Vang; Ingrid Safina; Emilie Darrigues; Dmitry Nedosekin; Zeid A Nima; Waqar Majeed; Fumiya Watanabe; Ganesh Kannarpady; Rajshekhar A Kore; Daniel Casciano; Vladimir P Zharov; Robert J Griffin; Ruud P M Dings; Alexandru S Biris
Journal:  Sci Rep       Date:  2017-07-14       Impact factor: 4.379

Review 4.  MHC class II antigen presentation by dendritic cells regulated through endosomal sorting.

Authors:  Toine ten Broeke; Richard Wubbolts; Willem Stoorvogel
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-12-01       Impact factor: 10.005

Review 5.  Novel Insights Into the Immunoregulatory Function and Localization of Dendritic Cells.

Authors:  Takaaki Hattori; Hiroki Takahashi; Reza Dana
Journal:  Cornea       Date:  2016-11       Impact factor: 2.651

Review 6.  Modulation of Host Immunity by the Human Metapneumovirus.

Authors:  Pablo F Céspedes; Christian E Palavecino; Alexis M Kalergis; Susan M Bueno
Journal:  Clin Microbiol Rev       Date:  2016-10       Impact factor: 26.132

7.  The role of dendritic cells in the mechanism of action of a peptide that ameliorates lupus in murine models.

Authors:  Uri Sela; Amir Sharabi; Molly Dayan; Rami Hershkoviz; Edna Mozes
Journal:  Immunology       Date:  2008-11-24       Impact factor: 7.397

8.  TNF-alpha-treated DC exacerbates disease in a murine tumor metastasis model.

Authors:  Nasreen Vohra; Monique Verhaegen; Lisa Martin; Amy Mackay; Shari Pilon-Thomas
Journal:  Cancer Immunol Immunother       Date:  2010-05       Impact factor: 6.968

9.  Murine neonates develop vigorous in vivo cytotoxic and Th1/Th2 responses upon exposure to low doses of NIMA-like alloantigens.

Authors:  Shannon J Opiela; Robert B Levy; Becky Adkins
Journal:  Blood       Date:  2008-06-06       Impact factor: 22.113

10.  Linking innate and adaptive immunity: human Vgamma9Vdelta2 T cells enhance CD40 expression and HMGB-1 secretion.

Authors:  Shirin Kalyan; Anthony W Chow
Journal:  Mediators Inflamm       Date:  2009-10-13       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.